FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1148744000: Lisocabtagene maraleucel (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4551711011 Lisocabtagene maraleucel en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4551712016 Lisocabtagene maraleucel (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4551711011 Lisocabtagene maraleucel en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4551712016 Lisocabtagene maraleucel (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lisocabtagene maraleucel Is a Genetically modified T-cell (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Lisocabtagene maraleucel Is a Antineoplastic agent (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing lisocabtagene maraleucel (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lisocabtagene maraleucel Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only lisocabtagene maraleucel (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lisocabtagene maraleucel Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing lisocabtagene maraleucel in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lisocabtagene maraleucel Inferred relationship Existential restriction modifier (core metadata concept) 1
Lisocabtagene maraleucel only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lisocabtagene maraleucel Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start